サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1758015

細菌性疾患診断の世界市場

Bacterial Disease Diagnostics

出版日
ページ情報
英文 273 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
細菌性疾患診断の世界市場
出版日: 2025年06月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 273 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

細菌性疾患診断の世界市場は2030年までに160億米ドルに達する見込み

2024年に117億米ドルと推定される細菌性疾患診断の世界市場は、2024年から2030年にかけてCAGR 5.3%で成長し、2030年には160億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである細菌性疾患診断用消耗品は、CAGR 4.3%を記録し、分析期間終了時には100億米ドルに達すると予測されます。細菌性疾患診断機器セグメントの成長率は、分析期間中CAGR 7.2%と推定されます。

米国市場は32億米ドル、中国はCAGR 8.3％で成長すると予測

米国の細菌性疾患診断市場は2024年に32億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに32億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と5.2%と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界の細菌性疾患診断市場- 主要動向と促進要因まとめ

現代ヘルスケアにおいて細菌性疾患の正確な診断がこれまで以上に重要になる理由とは？

細菌性疾患診断は、細菌感染の持続的かつ発展的な脅威と公衆衛生への影響により、世界のヘルスケアシステムにおいて不可欠な柱となっています。正確でタイムリーな診断は、効果的な治療のためだけでなく、感染症の蔓延を防ぎ、入院期間を最小限に抑え、ヘルスケアコストを削減するためにも不可欠です。抗生物質耐性の増加は、今や世界的に重要な健康問題であるため、細菌感染とウイルス感染を区別し、抗菌薬の的を絞った使用を確実にすることがさらに重要になっています。誤診や発見の遅れは抗生物質の誤用につながり、耐性を悪化させ、治療の失敗を招きます。結核、肺炎、尿路感染症、細菌性髄膜炎、敗血症などの疾患は、合併症や死亡事故を回避するために、迅速かつ特異的な同定が必要です。先進地域でも開発途上地域でも、病院や長期介護施設におけるヘルスケア関連感染（HAI）の負担が増加しているため、より堅牢で迅速な診断ソリューションに対する需要が高まっています。さらに、人獣共通感染症病原体の出現と世界の旅行により、アウトブレイクの地理的範囲と複雑性が拡大し、診断インフラにさらなる圧力がかかっています。現在、医師、疫学者、公衆衛生機関は、患者ケアだけでなく、サーベイランス、アウトブレイク管理、抗生物質スチュワードシップにおいても、高度な診断ツールに大きく依存しています。ヘルスケアが価値ベースのモデルへと移行し続ける中、細菌性疾患診断は、エビデンスに基づく治療を通じてより良い臨床転帰を達成するための戦略的重要性を増しています。

技術革新は細菌性疾患診断ツールにどのような革命をもたらしているのか？

技術の進歩は、より正確で、より迅速で、より侵襲性の低い検査法を可能にし、細菌性疾患診断の状況を劇的に変化させています。分子診断、特にPCR（ポリメラーゼ連鎖反応）やリアルタイムPCRは、高い特異性と感度で細菌DNAを検出するためのゴールドスタンダードとなっています。次世代シーケンサー（NGS）は、特に培養技術では不十分な場合に、複雑な感染症における病原体の同定や抗生物質耐性遺伝子のマッピングに新たな道を開きつつあります。迅速なPOC（point-of-care）診断は、細菌感染をどこでどのように検出するかに変革をもたらし、遠隔地や資源が限られた環境でもリアルタイムで結果を得ることができます。マイクロ流体工学、バイオセンサー、ラボオンチップ装置、CRISPRベースの検出システムなどの技術革新は、診断のスピード、精度、小型化の限界を押し広げています。自動化とAIを活用した解析は、ラボのワークフローを合理化し、人的ミスを減らし、複雑な診断データの解釈において臨床医を支援する意思決定支援ツールを提供しています。例えば、AIは現在、顕微鏡画像やシーケンスデータを解析して細菌種を区別したり、抗生物質の感受性を予測したりすることができます。同時に、血液製剤とサンプル保存の進歩により、血液、唾液、喀痰、尿といった最小限の多様な生物学的サンプルから、より正確な検査が可能になり、患者の快適性とコンプライアンスが向上しています。これらの技術により、診断がより患者中心で迅速なものとなり、早期発見と個別化治療が確実なものとなっています。細菌性病原体の遺伝的・生化学的シグネチャーの解明が進むにつれ、診断技術はより統合され、インテリジェント化し、現代のヘルスケア・システムに不可欠なものとなりつつあります。

細菌性疾患診断の需要が多様な市場や用途で世界的に伸びているのはなぜですか？

細菌性疾患診断に対する世界の需要は、ヘルスケアインフラの拡大、疾病負担の増大、公衆衛生の優先順位向上などに後押しされ、先進国、発展途上国を問わず急増しています。先進諸国では、人口の高齢化、慢性疾患の併存、医療関連感染の抑制の必要性などが、高度な診断検査室や病院ベースの検査プラットフォームへの投資を促しています。一方、アジア太平洋、ラテンアメリカ、アフリカの新興市場では、政府主導のヘルスケア改革、中流階級の人口増加、伝染病の罹患率増加により需要が拡大しています。農村部や医療サービスが行き届いていない地域では、POC（ポイント・オブ・ケア）診断キットや携帯型検査機器が早期発見を可能にし、診断ギャップを縮小することで変革的な役割を果たしています。需要はヒトのヘルスケアにとどまらず、獣医学的診断、食品安全モニタリング、環境検査、バイオテロリズムへの備えなど、細菌検出が重要な分野すべてに及んでいます。COVID-19パンデミックは、強固な診断エコシステムの重要性を浮き彫りにし、より広範な感染症対策戦略の一環として、細菌検査能力へのさらなる関心と投資を促しました。さらに、抗菌薬スチュワードシップが世界的に重視されるようになったことで、病院や診療所では、標的治療を導き、不必要な抗生物質の使用を減らすために、診断法を日常診療の流れに組み込むようになっています。製薬企業も臨床試験において診断プラットフォームを活用し、患者の層別化、治療効果のモニタリング、コンパニオン診断薬の開発を進めています。政府、NGO、民間企業が連携して世界ヘルスの脅威に取り組む中、正確な細菌診断に対する広範かつ多部門にわたるニーズは、将来のヘルスケア回復力を形成する上で中心的な力となりつつあります。

細菌性疾患診断市場の持続的成長の要因は？

世界の細菌性疾患診断市場の成長は、感染症管理における診断の重要な役割を強化するヘルスケア、技術、規制、経済的要因の集結によって牽引されています。特に、治療の遅れや失敗を避けるために迅速かつ正確な同定が必要とされる薬剤耐性株を中心とした細菌感染症の世界の発生率の増加が、最も大きな促進要因の1つです。WHOやCDCのような機関によって義務付けられた抗菌薬スチュワードシップの推進は、医療従事者に責任ある処方プロトコルの一環として診断薬の採用を促しています。特にパンデミック対策や生体防御イニシアチブの下、診断薬開発に対する規制当局の支援や資金援助が、技術革新と市場開拓を加速させています。さらに、多くの国々で国家保健戦略に診断薬が組み込まれ、公衆衛生プログラムを通じて検査が利用できるようになりつつあります。技術面では、診断プラットフォームの小型化と分散型検査モデルの台頭により、診断がより利用しやすく費用対効果の高いものとなり、外来、プライマリケア、在宅ヘルスケアへの普及が進んでいます。遠隔医療やデジタルヘルスプラットフォームの普及は、診断結果をリアルタイムで伝送し、遠隔患者管理を強化するコネクテッド診断機器への需要を生み出しています。商業的には、診断薬業界は医療技術企業、バイオテクノロジー新興企業、学術機関の戦略的提携から恩恵を受けており、迅速なプロトタイピングとマルチターゲットプラットフォームを促進しています。消費者意識の高まりと家庭用検査キットの台頭も市場情勢に変化をもたらし、診断薬が日常生活者の手に渡るようになっています。これらの複合的な力により、細菌性疾患診断市場は、より迅速で、よりスマートで、より利用しやすい診断ソリューションを求める世界の急務と歩調を合わせながら、力強い成長軌道を描き続けています。

セグメント

製品（細菌性疾患診断用消耗品、細菌性疾患診断用機器）;エンドユース（病院エンドユース、研究所エンドユース）

調査対象企業の例（全42社）

  • Abbott
  • Beckman Coulter
  • Becton Dickinson（BD）
  • BioMerieux
  • Bio-Rad Laboratories
  • Bio-Techne
  • Bruker
  • Cepheid
  • Danaher
  • DiaSorin
  • Hologic
  • Luminex
  • Meridian Bioscience
  • Mitsubishi Chemical Medience
  • QIAGEN
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Trinity Biotech

AIインテグレーション

検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革します。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36333

Global Bacterial Disease Diagnostics Market to Reach US$16.0 Billion by 2030

The global market for Bacterial Disease Diagnostics estimated at US$11.7 Billion in the year 2024, is expected to reach US$16.0 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Bacterial Disease Diagnostic Consumables, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$10.0 Billion by the end of the analysis period. Growth in the Bacterial Disease Diagnostic Instruments segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 8.3% CAGR

The Bacterial Disease Diagnostics market in the U.S. is estimated at US$3.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Bacterial Disease Diagnostics Market - Key Trends & Drivers Summarized

Why Is Accurate Diagnosis of Bacterial Diseases More Critical Than Ever in Modern Healthcare?

Bacterial disease diagnostics have become an indispensable pillar in global healthcare systems due to the persistent and evolving threat of bacterial infections and their consequences on public health. Accurate, timely diagnosis is essential not only for effective treatment but also for preventing the spread of infectious diseases, minimizing hospital stays, and reducing healthcare costs. The rise of antibiotic resistance-now a critical global health issue-makes it even more important to differentiate between bacterial and viral infections, ensuring targeted use of antimicrobials. Misdiagnosis or delayed detection can lead to the misuse of antibiotics, worsening resistance and causing treatment failures. Diseases such as tuberculosis, pneumonia, urinary tract infections, bacterial meningitis, and sepsis require rapid and specific identification to avert complications or fatalities. In both developed and developing regions, the increasing burden of healthcare-associated infections (HAIs) in hospitals and long-term care facilities is driving demand for more robust and rapid diagnostic solutions. Moreover, the emergence of zoonotic bacterial pathogens and global travel has expanded the geographic reach and complexity of outbreaks, placing additional pressure on diagnostics infrastructure. Physicians, epidemiologists, and public health agencies now rely heavily on sophisticated diagnostic tools not just for patient care, but also for surveillance, outbreak management, and antibiotic stewardship. As healthcare continues to transition toward value-based models, bacterial disease diagnostics are gaining strategic importance in achieving better clinical outcomes through evidence-based treatment.

How Are Technological Innovations Revolutionizing Bacterial Disease Diagnostic Tools?

Technological advancements are dramatically reshaping the bacterial disease diagnostics landscape, enabling more precise, faster, and less invasive testing methods. Molecular diagnostics, particularly PCR (polymerase chain reaction) and real-time PCR, have become gold standards for detecting bacterial DNA with high specificity and sensitivity. Next-generation sequencing (NGS) is opening new avenues for identifying pathogens and mapping antibiotic resistance genes in complex infections, particularly in cases where culture techniques fall short. Rapid point-of-care (POC) diagnostics are transforming how and where bacterial infections are detected-allowing real-time results even in remote or resource-limited settings. Innovations such as microfluidics, biosensors, lab-on-a-chip devices, and CRISPR-based detection systems are pushing the boundaries of diagnostic speed, accuracy, and miniaturization. Automation and AI-powered analysis are streamlining lab workflows, reducing human error, and providing decision support tools that assist clinicians in interpreting complex diagnostic data. For example, AI can now analyze microscopy images or sequencing data to differentiate between bacterial species or predict antibiotic susceptibility. At the same time, advancements in sample preparation and preservation are allowing for more accurate testing from minimal and diverse biological samples-blood, saliva, sputum, or urine-improving patient comfort and compliance. These technologies are making diagnostics more patient-centered and responsive, ensuring early detection and personalized therapy. As research continues to unlock the genetic and biochemical signatures of bacterial pathogens, diagnostic technologies are becoming more integrated, intelligent, and indispensable in modern healthcare systems.

Why Is Global Demand for Bacterial Disease Diagnostics Growing Across Diverse Markets and Applications?

The global demand for bacterial disease diagnostics is rising sharply across both developed and developing regions, fueled by expanding healthcare infrastructure, a growing disease burden, and increased prioritization of public health. In developed countries, aging populations, chronic disease comorbidities, and the need to control healthcare-associated infections are prompting investments in advanced diagnostic laboratories and hospital-based testing platforms. Meanwhile, emerging markets in Asia-Pacific, Latin America, and Africa are witnessing growing demand due to government-led healthcare reform, rising middle-class populations, and the increasing incidence of communicable diseases. In rural and underserved areas, point-of-care diagnostic kits and portable testing devices are playing a transformative role by enabling early detection and reducing the diagnostic gap. The demand extends beyond human healthcare-veterinary diagnostics, food safety monitoring, environmental testing, and bioterrorism preparedness are all areas where bacterial detection is critical. The COVID-19 pandemic underscored the importance of robust diagnostic ecosystems, driving further interest and investment in bacterial testing capacity as part of broader infectious disease preparedness strategies. Additionally, the growing global emphasis on antimicrobial stewardship has led hospitals and clinics to integrate diagnostics into their routine care pathways to guide targeted treatment and reduce unnecessary antibiotic use. Pharmaceutical companies are also leveraging diagnostic platforms in clinical trials to stratify patients, monitor treatment efficacy, and develop companion diagnostics. As governments, NGOs, and private players align to tackle global health threats, the widespread and multi-sectoral need for accurate bacterial diagnostics is becoming a central force in shaping future healthcare resilience.

What Factors Are Driving the Sustained Growth of the Bacterial Disease Diagnostics Market?

The growth in the global bacterial disease diagnostics market is driven by a convergence of healthcare, technological, regulatory, and economic factors that reinforce the critical role of diagnostics in managing infectious diseases. One of the foremost drivers is the increasing global incidence of bacterial infections, particularly drug-resistant strains, which necessitate rapid and precise identification to avoid treatment delays or failures. The push for antimicrobial stewardship, mandated by institutions like the WHO and CDC, is prompting healthcare providers to adopt diagnostics as part of responsible prescribing protocols. Regulatory support and funding for diagnostic development, especially under pandemic preparedness and biodefense initiatives, are accelerating innovation and market access. Additionally, the integration of diagnostics into national health strategies in many countries is expanding test availability through public health programs. On the technological front, the miniaturization of diagnostic platforms and the rise of decentralized testing models are making diagnostics more accessible and cost-effective, thereby expanding reach into outpatient settings, primary care, and home healthcare. The growing prevalence of telemedicine and digital health platforms is creating demand for connected diagnostic devices that can transmit results in real-time, enhancing remote patient management. Commercially, the diagnostics industry is benefitting from strategic collaborations between medtech firms, biotech startups, and academic institutions, fostering rapid prototyping and multi-target platforms. Heightened consumer awareness and the rise of at-home test kits are also transforming the market landscape, placing diagnostics into the hands of everyday users. These combined forces are ensuring that the bacterial disease diagnostics market continues on a robust growth trajectory, evolving in step with the urgent global imperative for faster, smarter, and more accessible diagnostic solutions.

SCOPE OF STUDY:

The report analyzes the Bacterial Disease Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Bacterial Disease Diagnostic Consumables, Bacterial Disease Diagnostic Instruments); End-Use (Hospitals End-Use, Laboratories End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott
  • Beckman Coulter
  • Becton Dickinson (BD)
  • BioMerieux
  • Bio-Rad Laboratories
  • Bio-Techne
  • Bruker
  • Cepheid
  • Danaher
  • DiaSorin
  • Hologic
  • Luminex
  • Meridian Bioscience
  • Mitsubishi Chemical Medience
  • QIAGEN
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Trinity Biotech

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Bacterial Disease Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Infectious Diseases Throws the Spotlight on Bacterial Diagnostics
    • Surge in Antimicrobial Resistance (AMR) Propels Demand for Rapid and Accurate Diagnostic Tools
    • Expansion of Point-of-Care Testing Capabilities Expands the Addressable Market for Portable Diagnostic Kits
    • Focus on Speed and Specificity Strengthens the Business Case for Molecular Bacterial Detection
    • Government and WHO-Led Disease Control Programs Accelerate Investments in Diagnostic Infrastructure
    • Emergence of Multi-Drug Resistant Pathogens Spurs Development of Next-Gen Diagnostic Platforms
    • Integration of AI and Cloud Platforms Enhances Interpretation of Diagnostic Results
    • Growing Preference for Non-Invasive and Low-Volume Sampling Drives Innovation in Testing Methods
    • Hospital Infection Control Programs Throw the Spotlight on Routine Bacterial Surveillance Testing
    • Increasing Role of Public Health Labs and Academic Research Fuels Technology Commercialization
    • Rural Health and Mobile Clinic Initiatives Generate Demand for Field-Friendly Diagnostic Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bacterial Disease Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bacterial Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Bacterial Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Bacterial Disease Diagnostic Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Bacterial Disease Diagnostic Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Bacterial Disease Diagnostic Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Bacterial Disease Diagnostic Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Bacterial Disease Diagnostic Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Bacterial Disease Diagnostic Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: China 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Bacterial Disease Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Bacterial Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: France 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Bacterial Disease Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Bacterial Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: India 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Bacterial Disease Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Bacterial Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Bacterial Disease Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Bacterial Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Bacterial Disease Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Bacterial Disease Diagnostics by Product - Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Bacterial Disease Diagnostics by Product - Percentage Breakdown of Value Sales for Bacterial Disease Diagnostic Consumables and Bacterial Disease Diagnostic Instruments for the Years 2014, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Bacterial Disease Diagnostics by End-Use - Hospitals End-Use and Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Bacterial Disease Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Laboratories End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION